Form 4 for MGRX MANGOCEUTICALS, INC.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-09 · accession 0001641172-25-027218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-12 | 2025-09-09 | MGRX | JOHNSTON EUGENE M | CFO | A - Grant | $0.00 | +100.0K | 138.3K | +261% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-09 | A | A | 100,000 | $0.00 | 138,334 | D | — | — | (F1) Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3. |